|
1
|
Li Z, Zhang C, Lou C, Yan F, Mao Y, Hong X
and Zhang Y: Comparison of percutaneous cryosurgery and surgical
resection for the treatment of small hepatocellular carcinoma.
Oncol Lett. 6:239–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Asia-Pacific Working Party on Prevention
of Hepatocellular Carcinoma: Prevention of hepatocellular carcinoma
in the Asia-Pacific region: Consensus statements. J Gastroenterol
Hepatol. 25:657–663. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Conti F, Dall'Agata M, Gramenzi A and
Biselli M: Biomarkers for the early diagnosis of bacterial
infection and the surveillance of hepatocellular carcinoma in
cirrhosis. Biomark Med. 9:1343–1351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang
G and Zhang Y: lncRNA GAS(5) enhances G1 cell cycle arrest via
binding to YBX1 to regulate p21 expression in stomach cancer. Sci
Rep. 5:101592015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu X, Li D, Zhang W, Guo M and Zhan Q:
Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6
mRNA decay. EMBO J. 31:4415–4427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lakhotia SC: Long non-coding RNAs
coordinate cellular responses to stress. Wiley Interdiscip Rev RNA.
3:779–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paralkar VR and Weiss MJ: A new ‘Linc’
between noncoding RNAs and blood development. Genes Dev.
25:2555–2558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dhamija S and Diederichs S: From junk to
master regulators of invasion: lncRNA functions in migration, EMT
and metastasis. Int J Cancer. 139:269–280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song H, Sun W, Ye G, Ding X, Liu Z, Zhang
S, Xia T, Xiao B, Xi Y and Guo J: Long non-coding RNA expression
profile in human gastric cancer and its clinical significances. J
Transl Med. 11:2252013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Z, Shao YF, Tan L, Shi HJ, Chen SC and
Guo JM: Clinical significance of the low expression of FER1L4 in
gastric cancer patients. Tumor Biol. 35:9613–9617. 2014. View Article : Google Scholar
|
|
16
|
Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F
and Yan D: Long non-coding RNA Fer-1-like protein 4 suppresses
oncogenesis and exhibits prognostic value by associating with
miR-106a-5p in colon cancer. Cancer Sci. 106:1323–1332. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia T, Chen SC, Jiang Z, Shao Y, Jiang X,
Li P, Xiao B and Guo J: Long noncoding RNA FER1L4 suppresses cancer
cell growth by acting as a competing endogenous RNA and regulating
PTEN expression. Sci Rep. 5:134452015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiao Q and Li H: LncRNA FER1L4 suppresses
cancer cell proliferation and cycle by regulating PTEN expression
in endometrial carcinoma. Biochem Biophys Res Commun. 478:507–512.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malaney P and Dave V: Loss of PTEN
cooperates with mutant KRAS initiating EMT and increased stemness
in a mouse model of lung cancer. Mol Cancer Res. 12:B092014.
View Article : Google Scholar
|
|
20
|
Takashi K, Naozumi H, Kazuyoshi I, Koji S,
Daisuke A, Tomomi O and Yoshinori H: Gene modulation of
phosphorylation sites in tumor suppressor PTEN inhibits
hypoxia-induced phenotype changes through epithelial-mesenchymal
transition (EMT) in lung cancer. Am J Respirat Crit Care Med.
183:A35032011.
|
|
21
|
Cho BC, Kim SM, Hong YK and Kim H:
Increased PTEN instability-mediated Akt activation confers acquired
resistance to cetuximab and increased migration/invasion potentials
in non-small cell lung cancer. Clin Exp Metastas. 28:230. 2011.
|
|
22
|
Sun Y, Tian H and Wang L: Effects of PTEN
on the proliferation and apoptosis of colorectal cancer cells via
the phosphoinositol-3-kinase/Akt pathway. Oncol Rep. 33:1828–1836.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang D, Zhou PH, Wang W, Wang X, Li J,
Sun X and Zhang L: MicroRNA-616 promotes the migration, invasion
and epithelial-mesenchymal transition of HCC by targeting PTEN.
Oncol Rep. 35:366–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lindl T, Gross U, Ruhdel I, von Aulock S
and Völkel M: Guidance on determining indispensability and
balancing potential benefits of animal experiments with costs to
the animals with specific consideration of EU directive 2010/63/EU.
ALTEX. 29:219–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ray MA, Johnston NA, Verhulst S, Trammell
RA and Toth LA: Identification of markers for imminent death in
mice used in longevity and aging research. J Am Assoc Lab Anim Sci.
49:282–288. 2010.PubMed/NCBI
|
|
27
|
Broeckx BJG, Hitte C, Coopman F, Verhoeven
GE, De Keulenaer S, De Meester E, Derrien T, Alfoldi J,
Lindblad-Toh K, Bosmans T, et al: Improved canine exome designs,
featuring ncRNAs and increased coverage of protein coding genes.
Sci Rep. 5:128102015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qu ZP and Adelson DL: Identification and
comparative analysis of ncRNAs in human, mouse and zebrafish
indicate a conserved role in regulation of genes expressed in
brain. PLoS One. 7:e522752012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferro M, Altieri V, Montanaro V and
Cimmino A: Ultraconserved region (Ucrs) encoding ncrnas involvement
in bladder cancer tumorigenesis: A new(P)layer in the ‘dark
matter’. Anticancer Res. 33:22662013.
|
|
30
|
Hayes EL and Lewis-Wambi JS: Mechanisms of
endocrine resistance in breast cancer: An overview of the proposed
roles of noncoding RNA. Breast Cancer Res. 17:402015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Louro R, Smirnova AS and Verjovski-Almeida
S: Long intronic noncoding RNA transcription: Expression noise or
expression choice? Genomics. 93:291–298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang M, Huang J, He J, Yi Q, Zhang Z, Tu
L, Ma D and Yan J: FER1L4: A potential plasma biomarker to identify
gastric cancer with lymph node invasion. Int J Clin Exp Pathol.
9:1982–1988. 2016.
|
|
36
|
Lotan TL, Carvalho FLF, Peskoe SB, Hicks
JL, Good J, Fedor H, Humphreys E, Han M, Platz EA, Squire JA, et
al: PTEN loss is associated with upgrading of prostate cancer from
biopsy to radical prostatectomy. Mod Pathol. 28:128–137. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dawson H, Koelzer V, Karamitopoulou E,
Lugli A and Zlobec I: The role of the tumor suppressor PTEN in
colorectal cancer is highly dependent on the tumor area. Lab
Invest. 95:156a2015.
|
|
38
|
Keniry M and Parsons R: The role of PTEN
signaling perturbations in cancer and in targeted therapy.
Oncogene. 27:5477–5485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yazdani Y, Farazmandfar T, Azadeh H and
Zekavatian Z: The prognostic effect of PTEN expression status in
colorectal cancer development and evaluation of factors affecting
it: miR-21 and promoter methylation. J Biomed Sci. 23:92016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie SM, Lu ZY, Lin YZ, Shen LJ and Yin C:
Upregulation of PTEN suppresses invasion in Tca8113 tongue cancer
cells through repression of epithelial-mesenchymal transition
(EMT). Tumor Biol. 37:6681–6689. 2016. View Article : Google Scholar
|
|
41
|
Zhang X, Park JS, Park KH, Kim KH, Jung M,
Chung HC, Rha SY and Kim HS: PTEN deficiency as a predictive
biomarker of resistance to HER2-targeted therapy in advanced
gastric cancer. Oncolo. 88:76–85. 2015. View Article : Google Scholar
|
|
42
|
Guo C, Song WQ, Sun P, Jin L and Dai HY:
LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in
endometrial cancer cells. J Biomed Sci. 22:1002015. View Article : Google Scholar : PubMed/NCBI
|
